LETROZOLE

Generic: LETROZOLE

Aurobindo Pharma LimitedManufacturer
ORALRoute
LETROZOLEActive Substance
2019-01-11Original Approval

LETROZOLE is FDA application ANDA211717, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FATIGUE
6,184 reports
2
NEUTROPENIA
4,676 reports
3
NAUSEA
4,507 reports
4
DIARRHOEA
3,961 reports
5
MALIGNANT NEOPLASM PROGRESSION
3,695 reports
6
WHITE BLOOD CELL COUNT DECREASED
3,281 reports
7
ARTHRALGIA
3,041 reports
8
ALOPECIA
2,863 reports
9
NEOPLASM PROGRESSION
2,439 reports
10
ASTHENIA
2,382 reports